A Meeting of the FCCB Committee of the Company is scheduled on Wednesday, 19-August-2026 to consider and approve conversion a portion of funds raised through FCCBs into equity shares and allotment thereof.
FCCB Committee Meeting On Wednesday, 19-August-2026
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Investor Presentation
- Sudarshan Pharma Industries Ltd Press Release Aug 10 2026
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Sudarshan Pharma Industries Ltd Press Release Aug 09 2026
- Board Meeting Intimation for To Consider And Approve Financial Results For The Quarter Ended 30/June/2026
Later from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Aug 17 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Sudarshan Pharma Industries Ltd Press Release Aug 18 2026
- Sudarshan Pharma Industries Ltd Press Release Aug 22 2026
- Annual General Meeting Of The Company On Tuesday, 22/September/2026
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries